Skip to main content
logo
ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.065
-0.045 (-4.05%)
Jul 31, 2026, 2:51 PM EDT - Market open

ADC Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
79.1881.3670.8469.56209.9133.92
Revenue Growth
4.43%14.85%1.84%-66.86%518.89%-
Gross Profit
71.8275.5664.8967.03206.6132.52
Operating Income
-118.28-121.5-130.65-165.99-123.34-261.72
Net Income
-136.99-142.62-157.85-240.05-157.13-230.03
Earnings Per Share
-1.05-1.12-1.62-2.94-1.95-2.99
EPS Growth
------

Revenue by Geography
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
United States
76.1873.5569.2869.0674.91
Europe, The Middle East and Africa
37.811.560.5105
Total
79.1881.3670.8469.56209.91

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
231.01261.34250.87278.6326.44466.54
Total Debt
116.67116.49121.63122.91117.3814.6
Net Cash (Debt)
114.34144.85129.24155.69209.07451.95
Net Cash Growth
56.69%12.08%-16.99%-25.53%-53.74%4.59%
Net Cash Per Share
0.821.141.331.912.595.88

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-114.55-141.17-123.84-118.69-138.31-233.38
Capital Expenditures
-0.03-0.26-0.87-3.22-0.69-3.43
Free Cash Flow
-114.58-141.44-124.7-121.9-139-236.81
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
90.71%92.87%91.60%96.36%98.43%95.89%
Operating Margin
-149.39%-149.34%-184.44%-238.63%-58.76%-771.65%
Pretax Margin
-171.95%-174.06%-220.42%-280.94%-69.94%-741.53%
Profit Margin
-173.02%-175.31%-220.65%-337.16%-70.05%-741.53%
FCF Margin
-144.72%-173.85%-176.04%-175.25%-66.22%-698.20%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.725.462.781.961.4845.75